The global Advanced Parenteral Drug Market achieved a valuation of USD 2.64 billion in the year 2022, and this figure is projected to climb to a noteworthy USD 4.6 billion by 2032, with a compound annual growth rate (CAGR) of 7.2% throughout the anticipated period. This significant expansion is driven by the escalating prevalence of chronic ailments including cancer, diabetes, and autoimmune...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian